-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - events (myocardial infarction, new-onset angina, stroke,
transient ischemic attack, and peripheral vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
July 01, 2009 - events included PV stenosis, cardiac
tamponade, stroke and/or transient ischemic attack, and
peripheral vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
January 01, 2020 - Resistive exercise versus
resistive vibration exercise to counteract vascular adaptations to bed rest
-
effectivehealthcare-admin.ahrq.gov/products/osteoporosis-vibration-therapy/research-protocol
December 01, 2019 - Resistive exercise versus resistive vibration exercise to counteract vascular adaptations to bed rest
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
January 01, 2020 - nitroglycerin use), other cardiovascular conditions (e.g., valvular disease, aneurysms, peripheral vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - Stephen Mascioli,
MD, MPH
Chief Medical Officer
Covidien Vascular
Therapies
General As an industry … Cardio-vascular
Therapeutic Area
Lead
Ortho-McNeil
Janssen Scientific
Affairs
Payal Desai, … Cardio-vascular
Therapeutic Area
Lead
Ortho-McNeil
Janssen Scientific
Affairs
Payal Desai, … Cardio-vascular
Therapeutic Area
Lead
Ortho-McNeil
Janssen Scientific
Affairs
Payal Desai, … Cardio-vascular
Therapeutic Area
Lead
Ortho-McNeil
Janssen Scientific
Affairs
Payal Desai,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
January 01, 2012 - disease,6 and is
an important modifiable risk factor for coronary artery
disease, stroke, peripheral vascular … Age-specific
relevance of usual blood pressure to vascular mortality.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - divided into adults and pediatric
populations), obstetrics, aortic aneurysm, prostate
surgery, other vascular … clotting
disorders (4 percent), secondary clotting disorders
(4 percent), and aortic aneurysm and other vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - proangiogenic growth factor receptors purportedly involved in the
pathogenesis of IPF, including vascular … intracellular signaling by inhibiting the proliferative growth factor receptor kinase
activity of vascular … solution also contains a low concentration of potassium ions to reduce free-radical generation
and avoid vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - over long-term effects of
extended-release exenatide, “particularly those associated with cardio-vascular
-
effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
December 01, 2020 - Histamine stimulation of the histamine-1 (H1) receptors on sensory nerves causes vascular dilation and … Leukotrienes also increase vascular permeability.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
February 01, 2009 - nitroglycerin use), other cardiovascular conditions (e.g.,
valvular disease, aneurysms, peripheral vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2024-surv-rep-update-table-appendix-e.xlsx
January 01, 2024 - 0.32 to 0.71)
Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50)
Vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
January 01, 2024 - 0.32 to 0.71)
Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50)
Vascular
-
effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy-2010/research-protocol
December 01, 2020 - inspiratory flow (and hence nasal patency); in contrast, nasal congestion, as a result of nasal edema and vascular … The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - Padeliporfin vascular-targeted
photodynamic therapy versus active
surveillance in men with low-risk
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
March 01, 2020 - Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Riociguat purportedly
vasodilates pulmonary and systemic arterial vascular beds; it is intended for … valve surgery.118
Manufacturer and regulatory status: The MitraClip is manufactured by the Abbott Vascular … Menlo Park (CA): Abbott
Vascular; 2013 Feb 01 [accessed 2014 Dec 10].
[2 p]. … Abbott Vascular.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
January 01, 2009 - 2,329 1,193 3,231 1,891 5,351 2,710 916 545 4,246 2,436 605 301 134 57 37 19 4,392 2,374
Cardio-
vascular … 3,566 1,830 5,658 3,361 7,749 3,131 1,401 808 7,064 3,665 900 447 227 86 101 58 8,009 4,028
Cardio-
vascular … 3,268 1,481 6,563 3,794 5,624 2,094 1,468 834 5,349 2,352 970 476 263 100 219 117 8,707 4,129
Cardio-
vascular … 1,305 7,269 4,207 5,345 2,129 1,515 884 5,838 2,703 1,006 507 309 123 321 162 9,019 4,487
Cardio-
vascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - in
3
37
Toulouse146 CABG 12 43 36 54 <40 in
3
38
HTN=hypertension; PVD=peripheral vascular … angina
%
Un-
stable
Angina
%
Ejection
Fraction
(mean)
Prior
stroke
%
Periph-
eral
vascular … ο Calculated N
Claudication ο Calculated N
Peripheral Vascular … Disease ο Calculated N
Prior Vascular Surgery ο Calculated N
Other coronary